Sanofi plans to buy more shares in Regeneron

02/12/2013 | Reuters

Sanofi plans to increase its stake in longtime drug development partner Regeneron Pharmaceuticals by purchasing shares on the open market. Sanofi holds a 16.7% stake in Regeneron. An agreement gives Sanofi the right to boost its stake in Regeneron to up to 30%. The two companies are jointly developing drugs for rheumatoid arthritis and cholesterol.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC